{
  "slide_id": "Slide34",
  "model": "OpenGVLab/InternVL3-14B",
  "prompt": "triples",
  "raw_output": "{\n  \"triples\": [\n    {\"s\":\"MRI contrast agents\", \"p\":\"uses\", \"o\":\"gadolinium-based agents\", \"modalities\":[\"text\"], \"confidence\":1.0, \"evidence\":\"MRI contrast agents are not entirely harmless. Research in recent years has revealed that gadolinium-based agents...\"},\n    {\"s\":\"EMA\", \"p\":\"launched\", \"o\":\"investigation\", \"modalities\":[\"text\"], \"confidence\":1.0, \"evidence\":\"In response to this growing concern, the European Medicines Agency, or EMA, launched an extensive investigation.\"},\n    {\"s\":\"EMA committee\", \"p\":\"reviewed\", \"o\":\"evidence\", \"modalities\":[\"text\"], \"confidence\":1.0, \"evidence\":\"In 2017, their committee reviewed evidence showing that traces of gadolinium could persist in brain tissues for many months after a single injection.\"},\n    {\"s\":\"EMA\", \"p\":\"suspended\", \"o\":\"linear gadolinium-based contrast agents\", \"modalities\":[\"text\"], \"confidence\":1.0, \"evidence\":\"Following this review, the EMA decided to take precautionary action. They suspended several widely used linear gadolinium",
  "parsed": {
    "s": "EMA committee",
    "p": "reviewed",
    "o": "evidence",
    "modalities": [
      "text"
    ],
    "confidence": 1.0,
    "evidence": [
      "In 2017, their committee reviewed evidence showing that traces of gadolinium could persist in brain tissues for many months after a single injection."
    ]
  }
}